September 20, 2010 - Interim six-month results for a stent system designed to treat bifurcation lesions will be presented during the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference in Washington, D.C.

September 20, 2010 – Patient enrollment has started in the EXCELLA BD Randomized Clinical Trial designed to evaluate Elixir Medical’s novolimus-eluting coronary stent with bioabsorbable coating, the Elixir DESyne BD. The first cases were enrolled by professor Joachim Schofer from the Universitäres Herz-und Gefä?zentrum in Hamburg, Germany, and Dr. Karl E.

September 17, 2010 - The Food and Drug Administration (FDA) cleared the first device that combines an angioplasty balloon and an embolic capturing feature. Angioslide's Proteus device is presently indicated for use in the lower limbs during Percutaneous Transluminal Angioplasty (PTA) procedures.

September 17, 2010 - The Cardiovascular Research Foundation's 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) symposium, to be held Sept. 21- 25, will feature presentations on Xience V data.

September 17, 2010 - Clinical uses will soon begin for the C3 Delivery System for the Gore Excluder Device as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm (AAA). The delivery system, made by W.L. Gore & Associates, provides surgeons with cannulation options and allows them to bring the contralateral gate to the contralateral guidewire.

September 16, 2010 – The features of the Infinix-i angiography systems that make the radial access approach more successful will be highlighted at the Transcatheter Cardiovascular Therapeutics (TCT) symposium Sept. 21-25 in Washington, D.C.